Published in Case Rep Transplant on November 26, 2012
Acute Liver Failure Occurring during the First Trimester of Pregnancy Successfully Treated with Living Donor Liver Transplantation. Case Rep Transplant (2013) 0.75
Liver Transplantation during Pregnancy for Acute Liver Failure due to HBV Infection: A Case Report. Case Rep Obstet Gynecol (2013) 0.75
A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology (2008) 1.86
Etiologies of acute liver failure. Semin Liver Dis (2008) 1.54
Fulminant hepatic failure during pregnancy successfully treated by orthotopic liver transplantation. Transplantation (1991) 1.50
Pregnancy and sexual function in liver transplantation. J Hepatol (2008) 1.49
Liver disease in pregnancy. Hepatology (2008) 1.42
Pregnancy and liver transplantation. Liver Int (2008) 1.00
Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev (2006) 0.98
Pregnancy and liver transplantation. Obstet Gynecol (1990) 0.98
Successful living related liver transplantation in an adult with fulminant hepatic failure. Transplantation (1997) 0.96
Living unrelated liver transplantation between spouses for fulminant hepatic failure. Br J Surg (1995) 0.95
An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl (1989) 0.92
Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: A case report. J Med Case Rep (2011) 0.88
Liver transplantation during pregnancy complicated by cytomegalovirus infection. Transplantation (1995) 0.87
Intrapartum orthotopic liver transplantation with successful outcome of pregnancy. Transplantation (1990) 0.85
Ischemic injury to the fetus after maternal liver transplantation. J Ultrasound Med (1994) 0.85
Liver transplantation during pregnancy. Transplant Proc (1993) 0.85
Successful liver transplantation and delivery in a woman with fulminant hepatic failure occurring during the second trimester of pregnancy. Liver Int (2006) 0.85
Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation (2002) 0.84
Successful outcome after a technically challenging liver transplant during pregnancy. Transplant Proc (2007) 0.84
[Liver transplantation during pregnancy in a patient with acute liver failure]. Acta Gastroenterol Latinoam (2010) 0.83
Acute liver failure at 26 weeks' gestation in a patient with sickle cell disease. Liver Transpl (2009) 0.81
Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med (1997) 0.81
The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology (2012) 2.61
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol (2002) 2.55
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. J Clin Oncol (2013) 2.44
A survey of liver transplantation from living adult donors in the United States. N Engl J Med (2003) 2.37
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol (2004) 2.12
Evaluating the potential living liver donor. Liver Transpl (2004) 1.64
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res (2009) 1.60
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl (2003) 1.57
Anatomical, histologic, and genetic characteristics of congenital chest wall deformities. Semin Thorac Cardiovasc Surg (2009) 1.47
Are patients with elevated liver tests at increased risk of drug-induced liver injury? Gastroenterology (2004) 1.21
Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl (2002) 1.15
Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria. Liver Transpl (2010) 1.15
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol (2005) 1.02
Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc (2005) 1.01
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology (2005) 1.00
Invasive biliary mucinous cystic neoplasm: a review. HPB (Oxford) (2012) 1.00
Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod Pathol (2009) 0.99
The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. J Surg Oncol (2013) 0.94
Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study. Pancreas (2008) 0.92
Region 11 MELD Na exception prospective study. Ann Hepatol (2011) 0.91
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy. J Clin Oncol (2009) 0.90
Gastric elastofibroma. Am Surg (2010) 0.90
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection. HPB (Oxford) (2014) 0.89
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology (2010) 0.88
Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literature. World J Gastroenterol (2006) 0.88
Liver function tests and statins. Curr Opin Cardiol (2011) 0.87
Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors. Liver Transpl (2003) 0.87
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery. J Proteome Res (2011) 0.86
Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology (2002) 0.85
Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl (2006) 0.85
Clinical and histopathologic features of chordomas in children and young adults. Pediatr Dev Pathol (2010) 0.83
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. J Surg Res (2012) 0.83
Discovery of putative pancreatic cancer biomarkers using subcellular proteomics. J Proteomics (2010) 0.83
Coronary artery stents and antiplatelet therapy in patients with cirrhosis. J Clin Gastroenterol (2012) 0.81
Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising. J Clin Lipidol (2008) 0.80
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics. Cancer Genomics Proteomics (2012) 0.80
SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases. Am J Surg Pathol (2015) 0.79
Laser excision of multiple esophageal lymphangiomas: a case report and review of the literature. Auris Nasus Larynx (2008) 0.79
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Liver Int (2014) 0.79
The closure of iatrogenic membrane defects after amniocentesis and endoscopic intrauterine procedures. Fetal Diagn Ther (2004) 0.79
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Am J Gastroenterol (2006) 0.79
Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double-blind, placebo-, and active-controlled thorough QT study. J Clin Pharmacol (2014) 0.78
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months. Eur J Clin Pharmacol (2009) 0.77
Is severe recurrent hepatitis C more common after adult living donor liver transplantation? Hepatology (2004) 0.77
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig Dis Sci (2013) 0.77
Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study. Exp Clin Transplant (2016) 0.77
A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia. Anesth Analg (2005) 0.76
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy. Support Care Cancer (2009) 0.75
MELD and serum sodium. Hepatology (2005) 0.75
Response. Radiology (2013) 0.75
Reporting outcomes on living donor liver transplant. Liver Transpl (2005) 0.75
Clear-cell chondrosarcoma of the humerus. Radiol Case Rep (2015) 0.75
The evaluation of drug rechallenge: the casopitant Phase III program. Regul Toxicol Pharmacol (2010) 0.75
Combined sonographic and endoscopic umbilical cord occlusion in twin and triplet gestations. J Perinat Med (2005) 0.75
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection. Dig Dis Sci (2013) 0.75
Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev Gastroenterol Hepatol (2014) 0.75
Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery? Obes Surg (2014) 0.75
Three-dimensional ultrasound to differentiate epigastric heteropagus conjoined twins from a TRAP sequence. Am J Obstet Gynecol (2004) 0.75